- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 34.43M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 22.83M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 7.5M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 7.5M sh |
| Shares Outstanding | Q3 2026 · Mar 31, 2026 | 34.43M sh |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $1.3M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $4.81M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $13.61M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $12.18M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $2.85M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $749.79K |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $1.65M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $639.79K |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $3.99M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $9.67M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $4.17M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $11.56M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $17.05M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $10.28M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $17.78M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $14.41M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.12 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.14 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.58 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.12 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.14 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.58 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.7M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $3.88M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $603.98K |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $1.8M |
| Net Income | Q3 2026 · Mar 31, 2026 | $142.41K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$2.8M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$1.07M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$4.35M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$1.58M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$3.4M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$329.51K |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$1.49M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $979.54K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $2.77M |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | $378.1K |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | $474.4K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $348.19K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $2.33M |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $119.18K |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $240.97K |
| Revenue | Q3 2026 · Mar 31, 2026 | $1.33M |
| Revenue | Q3 2026 · Mar 31, 2026 | $5.11M |
| Revenue | Q3 2026 · Mar 31, 2025 | $497.28K |
| Revenue | Q3 2026 · Mar 31, 2025 | $715.36K |
| Stock Repurchased restated | Q3 2026 · Mar 31, 2025 | $592.16K |
| Capex restated | Q3 2026 · Mar 31, 2025 | $10.9K |